Imprivata, a health IT security developer, is being acquired by Thoma Bravo for approximately $544 million. This strategic move aims to enhance product offerings and position the company for market growth. Thoma Bravo’s experience in security and healthcare IT is seen as beneficial for Imprivata’s mission critical technologies. Shareholders will receive $19.25 per share in cash, a 33% premium.
Apple issues mercenary spyware threat notifications
Apple has sent threat notifications to certain individuals it suspects may have been targeted by mercenary spyware attacks.
